Short Interest in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Decreases By 59.2%

Posted by Dante Gardener on Oct 11th, 2024

Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Free Report) was the target of a significant decrease in short interest in the month of September. As of September 30th, there was short interest totalling 39,900 shares, a decrease of 59.2% from the September 15th total of 97,700 shares. Based on an average daily volume of 2,170,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.2% of the shares of the stock are short sold.

Bluejay Diagnostics Price Performance

BJDX stock opened at $0.12 on Friday. The company has a market capitalization of $39,614.40, a P/E ratio of 0.00 and a beta of 0.70. The company has a 50-day simple moving average of $0.21 and a 200 day simple moving average of $2.29. Bluejay Diagnostics has a fifty-two week low of $0.11 and a fifty-two week high of $38.96.

Bluejay Diagnostics (NASDAQ:BJDX – Get Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($5.12) earnings per share for the quarter.

Institutional Investors Weigh In On Bluejay Diagnostics

A hedge fund recently bought a new stake in Bluejay Diagnostics stock. CVI Holdings LLC purchased a new stake in Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 66,165 shares of the company’s stock, valued at approximately $46,000. CVI Holdings LLC owned about 19.69% of Bluejay Diagnostics at the end of the most recent quarter. 18.47% of the stock is owned by institutional investors and hedge funds.

About Bluejay Diagnostics

(Get Free Report)

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.